A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Public ClinicalTrials.gov record NCT02571036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Phase 1, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, Efficacy, and Pharmacokinetics in Patients With Advanced Malignancies
Study identification
- NCT ID
- NCT02571036
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Deciphera Pharmaceuticals, LLC
- Industry
- Enrollment
- 282 participants
Conditions and interventions
Interventions
- DCC-2618 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2015
- Primary completion
- Apr 28, 2022
- Completion
- Apr 28, 2022
- Last update posted
- Dec 12, 2023
2015 – 2022
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Honor Health (GIST, mastocytosis, other solid tumors) | Scottsdale | Arizona | 85258 | — |
| UCLA Hematology Center (mastocytosis) | Los Angeles | California | 90024 | — |
| UCLA (glial malignancies only) | Los Angeles | California | 90095 | — |
| Stanford University Comprehensive Cancer Center (GIST) | Palo Alto | California | 94304 | — |
| Stanford University Hematology Clinic (mastocytosis) | Palo Alto | California | 94305 | — |
| UCSF (glial malignancies only) | San Francisco | California | 94143 | — |
| Mayo Clinic (GIST, mastocytosis, glial malignancies, other solid tumors) | Jacksonville | Florida | 32224 | — |
| University of Miami (GIST, mastocytosis, glial malignancies, other solid tumors) | Miami | Florida | 33136 | — |
| Dana Farber Cancer Institute (GIST, mastocytosis, glial malignancies, other solid tumors) | Boston | Massachusetts | 02215 | — |
| Colombia University Medical Center (mastocytosis) | New York | New York | 10032 | — |
| Memorial Sloan Kettering Cancer Center (GIST, mastocytosis, glial malignancies, other solid tumors) | New York | New York | 10065 | — |
| OHSU (GIST & mastocytosis only) | Portland | Oregon | 97239 | — |
| Fox Chase Cancer Center (GIST only) | Philadelphia | Pennsylvania | 19111 | — |
| MD Anderson Cancer Center (GIST, mastocytosis, glial malignancies, other solid tumors) | Houston | Texas | 77030 | — |
| Huntsman Cancer Institute (GIST, mastocytosis, glial malignancies, other solid tumors) | Salt Lake City | Utah | 84103 | — |
| Virginia Commonwealth University School of Medicine (mastocytosis) | Richmond | Virginia | 23219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02571036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2023 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02571036 live on ClinicalTrials.gov.